Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties

Inclusion Criteria

• •Patients over 18 years old.
• •Patients that were treated with the sagitta EVL-R stem for an indication of arthroplasty and according to the Instruction For Use (IFU).
• •Primary or secondary arthrosis,
• •Advanced joint destruction resulting from rheumatoid arthritis or traumatic arthritis,
• •A fracture or an avascular necrosis,
• •Following a previous surgical operation, on condition that the new device does not interfere with the material in place.
• •indicated in the case of primary or secondary arthrosis, displaced sub-capital or transcervical fracture as well as stages I and IIB bone loss according to the PAPROWSKI classification.
• •The SAGITTA EVOLUTION for REVISION implant is recommended for indications according to the bone loss classifications of SOFCOT stages I to VI, PAPROSKY types I to VI and the AAOS types Ia to Ic.
• •Dysplasia